Related Experiment Video
Updated: Dec 28, 2025

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
Published on: June 7, 2020
DeepSnap-Deep Learning Approach Predicts Progesterone Receptor Antagonist Activity With High Performance
Yasunari Matsuzaka1, Yoshihiro Uesawa1
1Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Tokyo, Japan.
Abstract:
The progesterone receptor (PR) is important therapeutic target for many malignancies and endocrine disorders due to its role in controlling ovulation and pregnancy via the reproductive cycle. Therefore, the modulation of PR activity using its agonists and antagonists is receiving increasing interest as novel treatment strategy. However, clinical trials using the PR modulators have not yet been found conclusive evidences. Recently, increasing evidence from several fields shows that the classification of chemical compounds, including agonists and antagonists, can be done with recent improvements in deep learning (DL) using deep neural network. Therefore, we recently proposed a novel DL-based quantitative structure-activity relationship (QSAR) strategy using transfer learning to build prediction models for agonists and antagonists. By employing this novel approach, referred as DeepSnap-DL method, which uses images captured from 3-dimension (3D) chemical structure with multiple angles as input data into the DL classification, we constructed prediction models of the PR antagonists in this study. Here, the DeepSnap-DL method showed a high performance prediction of the PR antagonists by optimization of some parameters and image adjustment from 3D-structures. Furthermore, comparison of the prediction models from this approach with conventional machine learnings (MLs) indicated the DeepSnap-DL method outperformed these MLs. Therefore, the models predicted by DeepSnap-DL would be powerful tool for not only QSAR field in predicting physiological and agonist/antagonist activities, toxicity, and molecular bindings; but also for identifying biological or pathological phenomena.
Insights
Deep learning models, using 3D chemical structures, accurately predict progesterone receptor (PR) antagonists. This novel DeepSnap-DL method outperforms traditional machine learning for drug discovery.
Area of Science:
- Pharmacology and Cheminformatics
- Artificial Intelligence in Drug Discovery
Background:
- The progesterone receptor (PR) is a key therapeutic target for various diseases.
- Modulating PR activity with agonists and antagonists is a promising treatment strategy, but clinical evidence is limited.
- Deep learning (DL) offers advanced methods for classifying chemical compounds.
Purpose of the Study:
- To develop and validate a novel DL-based quantitative structure-activity relationship (QSAR) strategy for predicting PR antagonists.
- To assess the performance of the proposed DeepSnap-DL method against conventional machine learning approaches.
Main Methods:
- A novel DL-based QSAR strategy, DeepSnap-DL, was developed using transfer learning.
- The method utilizes 3D chemical structure images from multiple angles as input for DL classification.
- Prediction models for PR antagonists were constructed and optimized.
Main Results:
- The DeepSnap-DL method demonstrated high predictive performance for PR antagonists.
- Optimization of parameters and image adjustments further improved model accuracy.
- DeepSnap-DL significantly outperformed traditional machine learning methods in prediction accuracy.
Conclusions:
- The DeepSnap-DL method is a powerful tool for QSAR, predicting various molecular activities and properties.
- This approach can aid in identifying biological phenomena and accelerating drug discovery for PR-related conditions.
Related Concept Videos
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

